James S. Ketter

Array ( [id] => 4044757 [patent_doc_number] => 05908764 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Methods and compositions for increasing production of erythromycin' [patent_app_type] => 1 [patent_app_number] => 8/861450 [patent_app_country] => US [patent_app_date] => 1997-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 9103 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908764.pdf [firstpage_image] =>[orig_patent_app_number] => 861450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010730 [patent_doc_number] => 05879892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Leukemia associated genes' [patent_app_type] => 1 [patent_app_number] => 8/845998 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21439 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/879/05879892.pdf [firstpage_image] =>[orig_patent_app_number] => 845998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288363 [patent_doc_number] => 06235498 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Method for culturing recombinant cells' [patent_app_type] => 1 [patent_app_number] => 8/845698 [patent_app_country] => US [patent_app_date] => 1997-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 10344 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235498.pdf [firstpage_image] =>[orig_patent_app_number] => 845698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404620 [patent_doc_number] => 06232117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Method for culturing recombinant cells' [patent_app_type] => 1 [patent_app_number] => 8/843434 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 10357 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232117.pdf [firstpage_image] =>[orig_patent_app_number] => 843434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3830835 [patent_doc_number] => 05814452 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus' [patent_app_type] => 1 [patent_app_number] => 8/806551 [patent_app_country] => US [patent_app_date] => 1997-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 10330 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814452.pdf [firstpage_image] =>[orig_patent_app_number] => 806551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3744481 [patent_doc_number] => 05716830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus' [patent_app_type] => 1 [patent_app_number] => 8/805596 [patent_app_country] => US [patent_app_date] => 1997-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 10325 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716830.pdf [firstpage_image] =>[orig_patent_app_number] => 805596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936375 [patent_doc_number] => 05871923 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Methods for screening for antimycotics' [patent_app_type] => 1 [patent_app_number] => 8/802626 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 30674 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871923.pdf [firstpage_image] =>[orig_patent_app_number] => 802626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3964268 [patent_doc_number] => 05885833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Nucleic acid constructs for the cell cycle-regulated expression of genes and therapeutic methods utilizing such constructs' [patent_app_type] => 1 [patent_app_number] => 8/798738 [patent_app_country] => US [patent_app_date] => 1997-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12938 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885833.pdf [firstpage_image] =>[orig_patent_app_number] => 798738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3929834 [patent_doc_number] => 05877302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Compacted nucleic acids and their delivery to cells' [patent_app_type] => 1 [patent_app_number] => 8/716415 [patent_app_country] => US [patent_app_date] => 1997-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 35 [patent_no_of_words] => 31266 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877302.pdf [firstpage_image] =>[orig_patent_app_number] => 716415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3963402 [patent_doc_number] => 05885776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Glaucoma compositions and therapeutic and diagnositic uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/791347 [patent_app_country] => US [patent_app_date] => 1997-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 33430 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885776.pdf [firstpage_image] =>[orig_patent_app_number] => 791347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3865625 [patent_doc_number] => 05837464 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening' [patent_app_type] => 1 [patent_app_number] => 8/790963 [patent_app_country] => US [patent_app_date] => 1997-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 67 [patent_no_of_words] => 56312 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837464.pdf [firstpage_image] =>[orig_patent_app_number] => 790963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4205697 [patent_doc_number] => 06027915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Expression augmenting sequence elements (EASE) for eukaryotic expression systems' [patent_app_type] => 1 [patent_app_number] => 8/785150 [patent_app_country] => US [patent_app_date] => 1997-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10632 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/027/06027915.pdf [firstpage_image] =>[orig_patent_app_number] => 785150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4120754 [patent_doc_number] => 06126964 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Process of making a compound by forming a polymer from a template drug' [patent_app_type] => 1 [patent_app_number] => 8/778657 [patent_app_country] => US [patent_app_date] => 1997-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12166 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/126/06126964.pdf [firstpage_image] =>[orig_patent_app_number] => 778657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727297 [patent_doc_number] => 05652112 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Assay for type I collagen carboxy-terminal telopeptide analytes' [patent_app_type] => 1 [patent_app_number] => 8/771219 [patent_app_country] => US [patent_app_date] => 1996-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 10010 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652112.pdf [firstpage_image] =>[orig_patent_app_number] => 771219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766442 [patent_doc_number] => 05773221 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Method of recovering a biological molecule from a recombinant microorganism' [patent_app_type] => 1 [patent_app_number] => 8/766308 [patent_app_country] => US [patent_app_date] => 1996-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13671 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773221.pdf [firstpage_image] =>[orig_patent_app_number] => 766308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741747 [patent_doc_number] => 05801016 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'DNA fragment, recombinant vector containing the same and method for expressing foreign genes using the same' [patent_app_type] => 1 [patent_app_number] => 8/750007 [patent_app_country] => US [patent_app_date] => 1996-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6692 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801016.pdf [firstpage_image] =>[orig_patent_app_number] => 750007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831006 [patent_doc_number] => 05712119 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Methods and compositions for high protein production form recombinant DNA' [patent_app_type] => 1 [patent_app_number] => 8/757300 [patent_app_country] => US [patent_app_date] => 1996-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13348 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712119.pdf [firstpage_image] =>[orig_patent_app_number] => 757300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3865601 [patent_doc_number] => 05837462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Tumorigenic cell lines altered by genetic engineering and their use for the testing of antitumor drugs' [patent_app_type] => 1 [patent_app_number] => 8/746383 [patent_app_country] => US [patent_app_date] => 1996-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 11242 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837462.pdf [firstpage_image] =>[orig_patent_app_number] => 746383 [rel_patent_id] =>[rel_patent_doc_number] =>)